Onivyde pegylated liposomal (previously Onivyde)
Active substance: irinotecan
irinotecan anhydrous free-base
Centralised EU authorisationActive
Marketing holder: Les Laboratoires Servier
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
- irinotecan anhydrous free-base
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 38 |
|
| US 27 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4db1-7abe-bdff-5f6ac76e8e63,01a1208d-428f-7d7f-b3b0-34c701cd36b0,01a1208d-4293-742b-a6d1-8cd104487370,01a1208d-5b4d-79f2-8c12-f3b412d76884,01a1208e-df71-74b2-a184-b9ba04383108;count=27 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/004125
- Registration status
- Active
- ATC code
- L01CE02
Sources
- product · EMA · EMEA/H/C/004125 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004125 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004125 · Verified 2026-10-09